ReviewMikrochimica acta2026
Microwave technologies for biomedical diagnosis and therapy: advances, challenges, and perspectives.
Review in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microwave technologies have emerged as powerful tools for biomedical diagnosis and therapy due to their non-ionizing nature, sensitivity to dielectric changes, and compatibility with compact, low-cost systems. This review provides a unified perspective that integrates the biophysical foundations of dielectric characterization with advances in biosensing, imaging, and therapeutic microwave platforms. A systematic examination of the primary material characterization techniques—non-resonant, transmission-line resonant, and metamaterial-based methods—highlights how their frequency-dependent interactions with biological media underpin molecular, cellular, and tissue-level sensing. We synthesize recent progress in microstrip and resonant biosensors for detecting biochemical, metabolic, oncological, and pathogenic biomarkers, alongside developments in microwave imaging for functional tissue assessment and energy-based therapies such as hyperthermia and ablation. This integrated framework clarifies how the methodological diversity of microwave systems supports increasingly specialized biomedical applications. Despite their promise, current microwave technologies face several barriers to clinical translation, including variability in dielectric models, calibration and reproducibility challenges, spatial-resolution constraints, and limited in vivo validation. Addressing these limitations requires advancing beyond traditional architectures. Accordingly, this review also consolidates emerging trends in microfluidics, wearable and implantable platforms, artificial intelligence (AI)-driven signal interpretation, and multimodal integration, illustrating how these capabilities enhance sensing performance, enable adaptive therapy monitoring, and advance microwave systems toward personalized theranostic applications. By articulating the interplay between methods, capabilities, and unresolved challenges, a comprehensive and timely roadmap is offered that distinguishes microwave technologies from conventional diagnostic modalities and underscores their unique potential in next-generation biomedical engineering.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.